{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:47:06Z","timestamp":1772196426346,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.09.010","type":"journal-article","created":{"date-parts":[[2008,9,20]],"date-time":"2008-09-20T04:40:50Z","timestamp":1221885650000},"page":"6083-6091","source":"Crossref","is-referenced-by-count":34,"title":["Towards a human oral vaccine for anthrax: The utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy"],"prefix":"10.1016","volume":"26","author":[{"given":"Leslie W.J.","family":"Baillie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiguang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Nataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.09.010_bib1","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/IAI.01242-06","article-title":"Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis","volume":"75","author":"Stokes","year":"2007","journal-title":"Infect Immun"},{"issue":"December (6866)","key":"10.1016\/j.vaccine.2008.09.010_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/414837a","article-title":"Delivering death in the mail","volume":"414","author":"Knight","year":"2001","journal-title":"Nature"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2008.09.010_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1369-5274(00)00168-5","article-title":"Bacillus anthracis, a bug with attitude!","volume":"4","author":"Baillie","year":"2001","journal-title":"Curr Opin Microbiol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2008.09.010_bib4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2672.2006.03112.x","article-title":"Past, imminent and future human medical countermeasures for anthrax","volume":"101","author":"Baillie","year":"2006","journal-title":"J Appl Microbiol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.09.010_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.jom.0000058345.05741.6b","article-title":"Analysis of adverse events after anthrax immunization in US Army medical personnel","volume":"45","author":"Wasserman","year":"2003","journal-title":"J Occup Environ Med"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.09.010_bib6","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"Williamson","year":"2005","journal-title":"Infect Immun"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2008.09.010_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.3.5.4459","article-title":"Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults","volume":"3","author":"Campbell","year":"2007","journal-title":"Hum Vac"},{"key":"10.1016\/j.vaccine.2008.09.010_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2008.09.010_bib9","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2008.09.010_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0264-410X(02)00579-0","article-title":"Experience with registered mucosal vaccines","volume":"21","author":"Dietrich","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.010_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000100515","article-title":"Vivotif\u2014a \u2018magic shield\u2019 for protection against typhoid fever and delivery of heterologous antigens","volume":"53","author":"Gentschev","year":"2007","journal-title":"Chemotherapy"},{"issue":"January (5\u20136)","key":"10.1016\/j.vaccine.2008.09.010_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0264-410X(02)00472-3","article-title":"Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors","volume":"21","author":"Pasetti","year":"2003","journal-title":"Vaccine"},{"issue":"September","key":"10.1016\/j.vaccine.2008.09.010_bib13","first-page":"1","article-title":"Salmonella vaccines for use in humans: present and future perspectives","volume":"752","author":"Garmory","year":"2002","journal-title":"FEMS Microbiol Rev"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.09.010_bib14","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1128\/IAI.71.7.3831-3836.2003","article-title":"Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge","volume":"71","author":"Garmory","year":"2003","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.09.010_bib15","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/j.1460-2075.1987.tb02580.x","article-title":"Release of a chimeric protein into the medium from Escherichia coli using the C-terminal secretion signal of haemolysin","volume":"6","author":"Mackman","year":"1987","journal-title":"EMBO J"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.09.010_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt0696-765","article-title":"An Escherichia coli haemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA","volume":"14","author":"Tzschaschel","year":"1996","journal-title":"Nat Biotechnol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.09.010_bib17","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1128\/IAI.72.12.7096-7106.2004","article-title":"Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded haemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA","volume":"72","author":"Galen","year":"2004","journal-title":"Infect Immun"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2008.09.010_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(03)00754-2","article-title":"Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin","volume":"115","author":"Wai","year":"2003","journal-title":"Cell"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.09.010_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1128\/IAI.68.1.205-213.2000","article-title":"In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors","volume":"68","author":"Pickett","year":"2000","journal-title":"Infect Immun"},{"issue":"August (28)","key":"10.1016\/j.vaccine.2008.09.010_bib20","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/S0264-410X(00)00142-0","article-title":"A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model","volume":"18","author":"Pasetti","year":"2000","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.09.010_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1472-765X.1998.00274.x","article-title":"Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis","volume":"26","author":"Miller","year":"1998","journal-title":"Lett Appl Microbiol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2008.09.010_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"Quinn","year":"2004","journal-title":"J Infect Dis"},{"issue":"April (1\u20132)","key":"10.1016\/j.vaccine.2008.09.010_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"Li","year":"2008","journal-title":"J Immunol Methods"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.09.010_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.09.010_bib25","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/IAI.00261-07","article-title":"Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax","volume":"75","author":"Albrecht","year":"2007","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.09.010_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2008.09.010_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.clpt.6100408","article-title":"HIV\/AIDS vaccines: 2007","volume":"82","author":"Robinson","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.09.010_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri1746","article-title":"Pre-erythrocytic malaria vaccines: towards greater efficacy","volume":"6","author":"Hill","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2008.09.010_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.clpt.6100420","article-title":"Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques","volume":"82","author":"Pasetti","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.09.010_bib30","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/IAI.70.9.5096-5106.2002","article-title":"Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen","volume":"70","author":"Londo\u00f1o-Arcila","year":"2002","journal-title":"Infect Immun"},{"issue":"September (27\u201328)","key":"10.1016\/j.vaccine.2008.09.010_bib31","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2004.03.025","article-title":"Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy","volume":"22","author":"Vindurampulle","year":"2004","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2008.09.010_bib32","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1128\/IAI.00356-07","article-title":"Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy","volume":"75","author":"Chinchilla","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.010_bib33","series-title":"Proceedings of the Tenth Annual Conference on Vaccine Research","article-title":"Non-human primate studies with a Salmonella Typhi-based anthrax vaccine","author":"Galen","year":"2007"},{"issue":"January (11)","key":"10.1016\/j.vaccine.2008.09.010_bib34","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.09.010_bib35","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"issue":"June (21\u201322)","key":"10.1016\/j.vaccine.2008.09.010_bib36","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin","volume":"20","author":"Gaur","year":"2002","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T23:49:55Z","timestamp":1557791395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":36,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X08012292"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}